Molecular simulations of SSTR2 dynamics and interaction with ligands

被引:6
|
作者
Gervasoni, Silvia [1 ]
Guccione, Camilla [1 ]
Fanti, Viviana [1 ,2 ]
Bosin, Andrea [1 ]
Cappellini, Giancarlo [1 ]
Golosio, Bruno [1 ,2 ]
Ruggerone, Paolo [1 ]
Malloci, Giuliano [1 ]
机构
[1] Univ Cagliari, Dept Phys, I-09042 Monserrato, Cagliari, Italy
[2] Ist Nazl Fis Nucleare Sez Cagliari, I-09042 Monserrato, Cagliari, Italy
关键词
2ND EXTRACELLULAR LOOP; RECEPTOR-TYPE; 2; SOMATOSTATIN ANALOGS; SOFTWARE;
D O I
10.1038/s41598-023-31823-1
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The cyclic peptide hormone somatostatin regulates physiological processes involved in growth and metabolism, through its binding to G-protein coupled somatostatin receptors. The isoform 2 (SSTR2) is of particular relevance for the therapy of neuroendocrine tumours for which different analogues to somatostatin are currently in clinical use. We present an extensive and systematic computational study on the dynamics of SSTR2 in three different states: active agonist-bound, inactive antagonist-bound and apo inactive. We exploited the recent burst of SSTR2 experimental structures to perform & mu;s-long multi-copy molecular dynamics simulations to sample conformational changes of the receptor and rationalize its binding to different ligands (the agonists somatostatin and octreotide, and the antagonist CYN154806). Our findings suggest that the apo form is more flexible compared to the holo ones, and confirm that the extracellular loop 2 closes upon the agonist octreotide but not upon the antagonist CYN154806. Based on interaction fingerprint analyses and free energy calculations, we found that all peptides similarly interact with residues buried into the binding pocket. Conversely, specific patterns of interactions are found with residues located in the external portion of the pocket, at the basis of the extracellular loops, particularly distinguishing the agonists from the antagonist. This study will help in the design of new somatostatin-based compounds for theranostics of neuroendocrine tumours.
引用
收藏
页数:10
相关论文
共 50 条
  • [11] SSTR2 Expression in Olfactory Neuroblastoma: Clinical and Therapeutic Implications
    Cracolici, Vincent
    Wang, Eric
    Gargano, Stacey
    Singhi, Aatur
    Seethala, Raja
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1188 - 1188
  • [12] A new approach for the development of tracers: data base screening and in silico modeling for the identification of new ligands for SSTR2
    Cheng, Caixia
    Pan, Leyun
    Dimitrakopoulou-Strauss, Antonia
    Strauss, Ludwig G.
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2008, 11 (02): : 101 - 104
  • [13] SUBTYPE-SPECIFIC SIGNALING MECHANISMS OF SOMATOSTATIN RECEPTORS SSTR1 AND SSTR2
    HOU, CF
    GILBERT, RL
    BARBER, DL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (14) : 10357 - 10362
  • [14] The effect of strength and endurance training on SSTR2 and SSTR5 in patients with colorectal cancer
    Zanjani, Farhad Safari
    Gaeni, Abbas Ali
    Aras, Dicle
    Akalan, Cengiz
    JOURNAL OF EXERCISE REHABILITATION, 2019, 15 (04) : 622 - 627
  • [15] Somatostatin Receptor 2 (SSTR2) Expression, as well as Combined Somatostatin and SSTR2 Expression, is Associated with Better Clinical Outcome and Prognosis in Rectal Neuroendocrine Tumors
    Kim, Joo Young
    Hong, Seung-Mo
    Kim, Jisup
    LABORATORY INVESTIGATION, 2024, 104 (03) : S738 - S738
  • [16] IMMUNOLOGICAL DETECTION OF ISOFORMS OF THE SOMATOSTATIN RECEPTOR SUBTYPE, SSTR2
    THEVENIAU, MA
    YASUDA, K
    BELL, GI
    REISINE, T
    JOURNAL OF NEUROCHEMISTRY, 1994, 63 (02) : 447 - 455
  • [17] SSTR2 Expression in Olfactory Neuroblastoma: Clinical and Therapeutic Implications
    Cracolici, Vincent
    Wang, Eric W.
    Gardner, Paul A.
    Snyderman, Carl
    Gargano, Stacey M.
    Chiosea, Simion
    Singhi, Aatur D.
    Seethala, Raja R.
    HEAD & NECK PATHOLOGY, 2021, 15 (04): : 1185 - 1191
  • [18] SSTR2 Expression in Olfactory Neuroblastoma: Clinical and Therapeutic Implications
    Vincent Cracolici
    Eric W. Wang
    Paul A. Gardner
    Carl Snyderman
    Stacey M. Gargano
    Simion Chiosea
    Aatur D. Singhi
    Raja R. Seethala
    Head and Neck Pathology, 2021, 15 : 1185 - 1191
  • [19] Overexpression of SSTR2 inhibited the growth of SSTR2-positive tumors via multiple signaling pathways
    Zhou, Tianhong
    Xiao, Xiaoping
    Xu, Bin
    Li, Hongjian
    Zou, Yi
    ACTA ONCOLOGICA, 2009, 48 (03) : 401 - 410
  • [20] A Retrospective Analysis of SSTR2 and MGMT Expression in Neuroendocrine Neoplasms
    Liu, Z.
    Chi, Y.
    Shi, S.
    Geng, H.
    NEUROENDOCRINOLOGY, 2019, 108 : 126 - 126